doi: 10.1200/JOP.0922001.
Physician-related factors involved in patient decisions to enroll onto cancer clinical trials
Affiliations
- PMID: 20856718
- PMCID: PMC2790653
- DOI: 10.1200/JOP.0922001
Item in Clipboard
Physician-related factors involved in patient decisions to enroll onto cancer clinical trials
J Oncol Pract.
2009 Mar.
Abstract
The development of new cancer therapies requires additional, and more complex, clinical trials. But only approximately 3% to 5% of adult cancer patients participate in cancer clinical trials. This study seeks to identify and understand the attitudes of the public and cancer survivors toward health-related decisions and cancer clinical trials to identify the key factors that must be addressed to increase that percentage.
Similar articles
-
Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.Clin Breast Cancer. 2005 Apr;6(1):45-54. doi: 10.3816/CBC.2005.n.008. Clin Breast Cancer. 2005. PMID: 15899072
-
Public attitudes regarding willingness to participate in medical research studies.J Health Soc Policy. 2000;12(2):23-43. doi: 10.1300/J045v12n02_02. J Health Soc Policy. 2000. PMID: 11184441
-
Public motives and willingness to participate in first-in-human clinical trials in Saudi Arabia: A new era in the making.J Infect Public Health. 2019 Sep-Oct;12(5):673-680. doi: 10.1016/j.jiph.2019.03.013. Epub 2019 Apr 18. J Infect Public Health. 2019. PMID: 31006634
-
Cancer patients' perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis.J Clin Nurs. 2019 Jul;28(13-14):2443-2461. doi: 10.1111/jocn.14785. Epub 2019 Mar 3. J Clin Nurs. 2019. PMID: 30673153 Review.
-
Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.Support Care Cancer. 2015 Apr;23(4):1169-96. doi: 10.1007/s00520-014-2581-9. Epub 2015 Jan 17. Support Care Cancer. 2015. PMID: 25591627 Review.
Cited by
-
Can we deconstruct cancer, one patient at a time?Trends Genet. 2013 Jan;29(1):6-10. doi: 10.1016/j.tig.2012.09.004. Epub 2012 Oct 23. Trends Genet. 2013. PMID: 23102584 Free PMC article.
-
Screening intervention to identify eligible patients and improve accrual to phase II-IV oncology clinical trials.J Oncol Pract. 2013 Jul;9(4):e174-81. doi: 10.1200/JOP.2012.000763. Epub 2013 Mar 5. J Oncol Pract. 2013. PMID: 23942936 Free PMC article.
-
"The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual".J Cancer Educ. 2012 Mar;27(1):67-74. doi: 10.1007/s13187-011-0271-6. J Cancer Educ. 2012. PMID: 21938600
-
[Acceptance and Related Causes of Clinical Trials among Cancer Patients in China].Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):41-49. doi: 10.3779/j.issn.1009-3419.2020.01.07. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948537 Free PMC article. Chinese.
-
Patient participation in cancer clinical trials: A pilot test of lay navigation.Contemp Clin Trials Commun. 2016 Aug 15;3:86-93. doi: 10.1016/j.conctc.2016.04.005. Contemp Clin Trials Commun. 2016. PMID: 27822566 Free PMC article.
References
-
- American Cancer Society: Cancer Facts and Figures 2001. Atlanta, GA, American Cancer Society, 2006
-
- Friedman MA, Cain DF: National Cancer Institute sponsored cooperative clinical trials. Cancer 65:2376-2382, 1990. (10 suppl) - PubMed
-
- Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med 10:789-799, 2004 - PubMed
-
- Druker BJ: Circumventing resistance to kinase-inhibitor therapy. N Engl J Med 354:2594-2596, 2006 - PubMed
-
- Comis RL, Miller JD, Aldige CR, et al: Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830-835, 2003 - PubMed
LinkOut - more resources
Full Text Sources
